Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 ...

Roger Li, MD, discusses factors influencing international doctors' attendance at the upcoming American Society of Clinical ...

The World Health Organization announced Tuesday it has officially adopted the first-ever "Pandemic Agreement," just as the ...

The largest Chinese licensing deal behind Pfizer’s is Novartis’ partnership with Shanghai Argo Biopharma, worth potentially ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

3SBio will grant Pfizer exclusive global rights, not including China, to develop, manufacture and commercialize SSGJ-707, a ...

Pfizer just penned a $6 billion licensing deal with China's 3SBio to develop and commercialize a cancer drug, SSGJ-707. The ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

A top court on Wednesday ruled that the European Commission had failed the transparency test by declining to release text ...

“Globally and locally, these partnerships underline our commitment to sustainable growth, offering unique, tailored experiences that resonate with diverse global audiences, while ensuring the ...